{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T19:33:11Z","timestamp":1783625591249,"version":"3.55.0"},"reference-count":42,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Philadelphia-like chromosome acute lymphoblastic leukemia (Ph-like ALL) is a new subtype of B-ALL that was discovered in 2009 and recognized in the 2016 revision of the World Health Organization criteria under the classification of myeloid neoplasms and acute leukemia. This new subtype has an extremely poor prognosis compared to that for other subtypes of ALL, with a 41% five-year overall survival (OS) rate. Ph-like ALL is chemoresistant, with a high minimum residual disease (MRD) level after induction therapy, and it is associated with a high relapse rate. Clinical trials are currently being conducted to study the effectiveness of specific tyrosine kinase inhibitors against different genetic alterations in Ph-like ALL patients and the effect of allogeneic hematopoietic cell transplants (allo-HCT) on treatments. This review summarizes the current findings on Ph-like ALL, focusing on its molecular landscape and clinical implications.<\/jats:p>","DOI":"10.3390\/diagnostics15030385","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T06:30:29Z","timestamp":1738823429000},"page":"385","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Integrative Insights into Philadelphia-like B-Cell Acute Lymphoblastic Leukemia: A Genetic and Molecular Landscape"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0591-6285","authenticated-orcid":false,"given":"Stacey","family":"Chuang","sequence":"first","affiliation":[{"name":"The International Circle of Genetic Studies Project, Stony Brook Chapter, Stony Brook, NY 11794, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8711-5420","authenticated-orcid":false,"given":"Alexandra","family":"Chu","sequence":"additional","affiliation":[{"name":"The International Circle of Genetic Studies Project, Stony Brook Chapter, Stony Brook, NY 11794, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3475-2361","authenticated-orcid":false,"given":"Rodrigo","family":"Hurtado","sequence":"additional","affiliation":[{"name":"The International Circle of Genetic Studies Project, Stony Brook Chapter, Stony Brook, NY 11794, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5339-5347","authenticated-orcid":false,"given":"Carlos A.","family":"Tirado","sequence":"additional","affiliation":[{"name":"The International Circle of Genetic Studies Project, Stony Brook Chapter, Stony Brook, NY 11794, USA"},{"name":"Department of Pathology, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11794, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.clml.2017.03.299","article-title":"Philadelphia Chromosome-like Acute Lymphoblastic Leukemia","volume":"17","author":"Pui","year":"2017","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1182\/blood-2017-06-743252","article-title":"Philadelphia chromosome-like acute lymphoblastic leukemia","volume":"130","author":"Tasian","year":"2017","journal-title":"Blood"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1182\/asheducation-2018.1.137","article-title":"Genetics and prognosis of ALL in children vs adults","volume":"2018","author":"Roberts","year":"2018","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"150","DOI":"10.5858\/arpa.2019-0194-RA","article-title":"BCR-ABL1\u2013like B-acute lymphoblastic leukemia\/lymphoma: A comprehensive review","volume":"144","author":"Jain","year":"2019","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1182\/asheducation-2016.1.561","article-title":"Ph-like acute lymphoblastic leukemia","volume":"2016","author":"Tran","year":"2016","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: Integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"ref_7","first-page":"1","article-title":"CRLF2 (Cytokine receptor like factor 2)","volume":"23","year":"2019","journal-title":"Atlas Genet. Cytogenet. Oncol. Haematol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Meyer, L., Delgado-Martin, C., Maude, S., Shannon, K.M., Teachey, D.T., and Hermiston, M.L. (2019). CRLF2 rearrangement in Ph-like acute lymphoblastic leukemia predicts relative glucocorticoid resistance that is overcome with MEK or Akt inhibition. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0220026"},{"key":"ref_9","unstructured":"(2024, November 11). National Library of Medicine, Available online: https:\/\/www.ncbi.nlm.nih.gov\/gene\/64109."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Gil, J.V., Miralles, A., Heras, S.d.L., Such, E., Avetisyan, G., D\u00edaz-Gonz\u00e1lez, \u00c1., Santiago, M., Fuentes, C., Fern\u00e1ndez, J.M., and Lloret, P. (2024). Comprehensive detection of CRLF2 alterations in acute lymphoblastic leukemia: A rapid and accurate novel approach. Front. Mol. Biosci., 11.","DOI":"10.3389\/fmolb.2024.1362081"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.1182\/blood-2009-09-245944","article-title":"Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic\/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia","volume":"115","author":"Harvey","year":"2010","journal-title":"Blood"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Zi\u0119tara, K.J., Wr\u00f3blewska, K., Zaj\u0105czkowska, M., Tacza\u0142a, J., and Lejman, M. (2024). The Role of the JAK\u2013STAT Pathway in Childhood B-Cell Acute Lymphoblastic Leukemia. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25136844"},{"key":"ref_13","unstructured":"Martinez-Anaya, D., Vera, P., and Juarez-Velazquez, R. (2024, May 15). Available online: https:\/\/atlasgeneticsoncology.org\/haematological\/1599\/del(x)(p22p22)-p2ry8-crlf2-br-del(y)(p11p11)-p2ry8-crlf2#section-9."},{"key":"ref_14","unstructured":"Ju\u00e1rez-Vel\u00e1zquez, R., Moreno-Lorenzana, D., P\u00e9rez-Vera, P., and Mart\u00cdnez-Anaya, D. (2017). t(X;14)(p22;q32) or t(Y;14)(p11;q32) IGH\/CRLF2. Atlas Genet. Cytogenet. Oncol. Haematol., Available online: http:\/\/atlasgeneticsoncology.org\/haematological\/1769\/t(x;14)(p22;q32)-or-t(y;14)(p11;q32)-igh-crlf2."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.3324\/haematol.2018.207506","article-title":"How I diagnose and manage Philadelphia chromosome-like acute lymphoblastic leukemia","volume":"104","author":"Frisch","year":"2019","journal-title":"Haematologica"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1016\/j.clml.2020.08.011","article-title":"Philadelphia-Like Acute Lymphoblastic Leukemia: A Systematic Review","volume":"21","author":"Yadav","year":"2021","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_17","unstructured":"Lefranc, M. (2000). IGH (Immunoglobulin Heavy). Atlas Genet. Cytogenet. Oncol. Haematol., Available online: http:\/\/atlasgeneticsoncology.org\/gene\/40\/igh-(immunoglobulin-heavy)."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ijbiomac.2013.05.029","article-title":"The effects of R683S (G) genetic mutations on the JAK2 activity, structure, and stability","volume":"60","author":"Li","year":"2013","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s00277-023-05241-2","article-title":"Philadelphia-like acute lymphoblastic leukemia: The journey from molecular background to the role of bone marrow transplant-review article","volume":"102","author":"Alghandour","year":"2023","journal-title":"Ann. Hematol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Paolino, J., Tsai, H.K., Harris, M.H., and Pikman, Y. (2024). IKZF1 Alterations and Therapeutic Targeting in B-Cell Acute Lymphoblastic Leukemia. Biomedicines, 12.","DOI":"10.3390\/biomedicines12010089"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1080\/10428194.2024.2396046","article-title":"IKZF1 in acute lymphoblastic leukemia: The rise before the fall?","volume":"65","author":"Boer","year":"2024","journal-title":"Leuk. Lymphoma"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Powell, M.D., Read, K.A., Sreekumar, B.K., and Oestreich, K.J. (2019). Ikaros Zinc Finger Transcription Factors: Regulators of Cytokine Signaling and CD4+ T Helper Cell Differentiation. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.01299"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Feng, L., Zhang, H., and Liu, T. (2024). Multifaceted roles of IKZF1 gene, perspectives from bench to bedside. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1383419"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Downes, C.E., McClure, B.J., McDougal, D.P., Heatley, S.L., Bruning, J.B., Thomas, D., Yeung, D.T., and White, D.L. (2022). JAK2 Alterations in Acute Lymphoblastic Leukemia: Molecular Insights for Superior Precision Medicine Strategies. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.942053"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1182\/asheducation-2014.1.174","article-title":"The genomic landscape of acute lymphoblastic leukemia in children and young adults","volume":"1","author":"Mullighan","year":"2014","journal-title":"Hematology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/bjh.17910","article-title":"Identification of a novel GOLGA4\u2013JAK2 fusion gene in B-cell acute lymphoblastic leukemia","volume":"196","author":"Downes","year":"2022","journal-title":"Br. J. Haematol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000516655","article-title":"International System for Human Cytogenetic or Cytogenomic Nomenclature (ISCN): Some Thoughts","volume":"161","author":"Hastings","year":"2021","journal-title":"Cytogenet. Genome Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/gcc.22995","article-title":"Sustained remission after ruxolitinib and chimeric antigen receptor T-cell therapy bridged to a second allogeneic hematopoietic stem cell transplantation for relapsed Philadelphia chromosome-like B-cell precursor acute lymphoblastic leukemia with novel NPHP3-JAK2 fusion","volume":"61","author":"Chen","year":"2022","journal-title":"Genes. Chromosomes Cancer"},{"key":"ref_29","first-page":"606","article-title":"Ph-like B-cell acute lymphoblastic leukemia with ZEB2-JAK2 fusion gene positivity: A case report","volume":"44","author":"Shen","year":"2023","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","article-title":"Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia","volume":"371","author":"Roberts","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1182\/bloodadvances.2019000163","article-title":"Clinical diagnostics and treatment strategies for Philadelphia chromosome\u2013like acute lymphoblastic leukemia","volume":"4","author":"Harvey","year":"2020","journal-title":"Blood Adv."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Shiraz, P., Payne, K.J., and Muffly, L. (2020). The Current Genomic and Molecular Landscape of Philadelphia-like Acute Lymphoblastic Leukemia. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21062193"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"101242","DOI":"10.1016\/j.beha.2021.101242","article-title":"Have any strategies in Ph-like ALL been shown to be effective?","volume":"34","author":"Aldoss","year":"2021","journal-title":"Best. Pract. Res. Clin. Haematol."},{"key":"ref_34","unstructured":"Haq, M., and Adnan, G. (2024, April 03). \u201cRuxolitinib\u201d, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK570600\/."},{"key":"ref_35","first-page":"554","article-title":"Philadelphia chromosome-like acute lymphoblastic leukemia: Progress in a new cancer subtype","volume":"15","author":"Wells","year":"2017","journal-title":"Clin. Adv. Hematol. Oncol."},{"key":"ref_36","unstructured":"(2024, May 21). National Center for Biotechnology Information, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Dasatinib."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1007\/s00277-023-05236-z","article-title":"Rapid molecular response to dasatinib in Ph-like acute lymphoblastic leukemia patients with ABL1 rearrangements: Case series and literature review","volume":"102","author":"Tan","year":"2023","journal-title":"Ann. Hematol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"He, G.-Q., Lei, Y.-P., Huang, D.-W., Gao, J., and Yang, R. (2024). Philadelphia chromosome-like acute lymphoblastic leukemia with concomitant rearrangements of CRLF2 and ABL1: A pediatric case report. BMC Pediatr., 24.","DOI":"10.1186\/s12887-024-04991-w"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1182\/blood-2016-07-726588","article-title":"Ph-like acute lymphoblastic leukemia: A high-risk subtype in adults","volume":"129","author":"Jain","year":"2016","journal-title":"Blood"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1016\/S2352-3026(20)30353-7","article-title":"Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: A multicentre, retrospective, cohort study","volume":"8","author":"Cario","year":"2021","journal-title":"Lancet Haematol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1200\/JCO.2016.69.0073","article-title":"High Frequency and Poor Outcome of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia in Adults","volume":"35","author":"Roberts","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41408-021-00538-9","article-title":"Identification of adult Philadelphia-like acute lymphoblastic leukemia using a FISH-based algorithm distinguishes prognostic groups and outcomes","volume":"11","author":"Heckman","year":"2021","journal-title":"Blood Cancer J."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/3\/385\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:27:40Z","timestamp":1760027260000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/3\/385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,6]]},"references-count":42,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["diagnostics15030385"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics15030385","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,6]]}}}